Alexion Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (4)

Latest Articles

About This Stock More About This Stock
Rayno Life Science Small Cap Picks: CLDX, PACB, FMI…Update-1
Article By: Rod Raynovich
Monday, November 17, 2014 12:00 PM EDT
Recent small cap picks.
In this article: ALXN, CLDX, GHDX, ILMN, REGN, SGEN, ALKS, GILD, PACB, KPTI, FMI, FCSC
Read
Eight Is Enough
Video By: Tim Knight
Thursday, November 6, 2014 5:42 PM EDT
Sharing the charting of eight long ideas. Video length: 4:48.
In this video: IP, JWN, TYL, ALXN, CAKE, DLTR, HSNI, ACCO
Watch
5 Great NASDAQ 100 Stocks
Article By: Jim Van Meerten
Thursday, October 30, 2014 4:55 PM EDT
NASDAQ 100, 5 stocks with the best technical buy signals.
In this article: ALXN, AAPL, ADP, AMGN, GMCR
Read
Insider Trading Report: Notable Buys And Sales
Article By: Asif Suria
Monday, September 29, 2014 4:47 AM EDT
Welcome to edition 223 of Insider Weekends. Insider buying decreased last week with insiders buying $30.92 million of stock compared to $49.49 million in the week prior. Selling increased with insiders selling $587.59 million of stock last week compared to $469.15 million in the week prior.
In this article: ANF, CCL, CLR, CRM, OPK, LJPC, ALXN, JAZZ, FB, RH
Read
Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside
Article By: The Life Sciences Report
Thursday, August 21, 2014 3:17 PM EDT
Liana Moussatos of Wedbush Securities doesn't wait for the catalyst to strike. She, like other successful investors, picks her targets and takes profits earlier, while less sophisticated investors wait for the press releases.
In this article: CPT, GALT, ALXN, OMER, PCRX, XOMA, UTHR
Read
Bring On The Orphans: Aegis Capital's Raghuram Selvaraju Lays Out A Winning Biotech Strategy
Article By: The Life Sciences Report
Thursday, August 14, 2014 6:48 AM EDT
For former drug researcher Raghuram "Ram" Selvaraju, picking biotech stocks is both science and art. It's about understanding the competitive landscape and the mechanisms of drug action, and then making sure all the pieces fit together for a plausible investment case.
In this article: AGN, AZN, GSK, JNJ, PFE, SNY, VRX, CUR, PLX, ACOR, ALXN, MDVN, SCLN, AUXL, ABBV
Read

Latest Tweets for $ALXN

No tweets yet!

PARTNER HEADLINES